Medicinal Cannabis: Economic Contribution Debate
Full Debate: Read Full DebateKarin Smyth
Main Page: Karin Smyth (Labour - Bristol South)Department Debates - View all Karin Smyth's debates with the Department of Health and Social Care
(1 year, 7 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is a pleasure to serve under your chairmanship, Mr Stringer, and to be present for this debate. I take what the right hon. Member for Dumfriesshire, Clydesdale and Tweeddale (David Mundell) said about it being in a late slot on a Thursday, but it is an important debate, and I am pleased that we have had time for contributions.
The right hon. Gentleman clearly outlined the case for a legitimate industry of the future. He asked the Government for consistency and coherence in their approach to the industry. I wish him luck on getting Government coherence on policy for many nascent industries, but the point was well made about good standards of production and the importance of jobs, particularly in rural economies such as the one he represents.
Many people present—and, on other occasions, many who could not be here this afternoon—have spoken movingly about constituents, as the hon. Member for Strangford (Jim Shannon) did. He spoke about the difference that earlier movement would have made to his nephew.
We welcome the constituents of the right hon. and learned Member for Kenilworth and Southam (Sir Jeremy Wright), who were present to hear the debate, as they have been on many similar occasions over the past few years. He made the sensible point that the 2018 decision logically necessitated action from the Government, and said that the insecure supply chain is worrying for so many families across the country. Having an industry in this country would alleviate that worry.
Finally, we heard from the hon. Member for Inverclyde (Ronnie Cowan), who has raised the issue 36 times. I work well with him on Committees, and he is a persistent campaigner on this and many other subjects, so I suspect he will be here for a 37th and a 38th time as well. He has done a huge amount of work in the area. He took us on a trip into history, and spoke about the importance of many such plants to the wider economy, and on the need for the Government to have more knowledge when it comes to the logic of their decision making on supporting the industry.
This debate is about the economy, and points have been made well. As we have a Health Minister present, however, it is worth recapping why we have not made greater progress since 2018, in particular for those campaigners who worked so hard. Despite that 2018 decision, the trials and clinical research that would help the wider industry have moved at a glacial pace, so across the NHS, since 2018 only five people have been prescribed medical cannabis. That is ridiculously slow, and so many people have to go private.
Five years later, it is totally unacceptable that so little progress has been made. It would be helpful if the Minister could set out what steps he is taking to empower and accelerate research in this space. I hope he will not dodge the question by saying that the issue is simply one for clinicians. The Government have a responsibility—the Minister is nodding, and we await his reply with interest, but there seems to be a lack of urgency on the issue, which is concerning. People are suffering right now. We have heard again this afternoon about children who are fitting, sometimes 100 times or more. Accessing care is, in some cases, pushing families to the brink of destitution. We should do everything we can to support those people.
If research is needed before clinicians feel comfortable prescribing, then it is incumbent on the Government to support clinicians. We need more streamlined clinical trials and better engagement with clinicians. We do not want to be back here in another two years, having a rerun of this debate. In 2020-21, the then Minister said:
“It will take time to generate further evidence and see the results of clinical trials. The Health Secretary and I are committed to doing everything in our power to accelerate this work.”—[Official Report, 4 November 2021; Vol. 702, c. 1120.]
If the Minister could update us on where this work has got to, and whether the Government are any closer to finding a solution, that would be welcomed by people tuning in today, and to the families present.
Finally, I would be grateful if the Minister set out what action he has taken to support people in the system right now—those living in extreme pain who are paying thousands of pounds to access treatment. There is consensus on this issue, as we have heard. The debate has been had and a decision has been made, but we can and should do better. In that spirit of consensus, we would all like to see some progress from the Minister.